Is Levodopa Response a Valid Indicator of Parkinson's Disease?
Abstract
The clinical diagnosis of Parkinson's disease (PD) requires the presence of parkinsonism and supportive criteria that include a clear and dramatic beneficial response to dopaminergic therapy. Our aim was to test the diagnostic criterion of dopaminergic response by evaluating its association with pathologically confirmed diagnoses in a large population of parkinsonian patients.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 30, 2020
- Source ID
- 10.1002/mds.28406
Entities
People
- Albert A Davis
- Baijayanta Maiti
- Brad A Racette
- Joel S Perlmutter
- Johanna Hartlein
- Michael Miles
- Mwiza Ushe
- Nigel J. Cairns
- Paul T. Kotzbauer
- Qiaonan Zhong
- Richard J Perrin
- Scott A Norris
- Susan Criswell
- W.r. Wayne Martin
Organizations
- American Parkinson Disease Association
- Mayo Clinic
- National Institute of Environmental Health Sciences
- National Institutes of Health
- St. Louis American Parkinson Disease Association
- The Michael J. Fox Foundation
- United States Department of Defense
- University of Alberta
- University of Exeter
- University of the Witwatersrand
- Washington University in St. Louis